Just after 8:30 a.m. on a recent Friday, the usual rush for coffee near Bay Street and Avenue Road was interrupted by a heartbreaking sight. A man, lost in the grip of addiction, stood swaying in a doorway, a crackpipe and cigarette clutched in his hands, unable to find the strength to even light them. This scene, tragically, is no longer a rarity in Toronto.
Open drug use – not casual marijuana smoking, but the blatant consumption of crack and meth – is becoming disturbingly commonplace. It unfolds on street corners, within the shelter of doorways, in public parks, and even on public transit. A quiet desperation hangs over the city, a sense that something fundamental has shifted.
A visitor from Barbados recently voiced what many Torontonians feel but hesitate to say. Observing someone struggling with addiction on a subway car, he declared, “I’ve never been to a city where everything that is wrong has been normalized.” He remembered a Toronto from a decade or two ago, a city he no longer recognizes.
The normalization isn’t accidental. It’s fueled, in part, by a system that inadvertently supports addiction. Millions of taxpayer dollars are spent annually on providing the very tools of substance abuse – crack pipes, syringes, and meth pipes. Freedom of Information requests revealed a staggering procurement: 2.34 million meth pipes, 3.45 million crack pipes, and nearly 15 million syringes distributed over just five years.
This practice is defended under the banner of “harm reduction,” the idea that providing clean supplies minimizes the risks associated with drug use. But the evidence suggests a different reality. Proponents claim it saves lives, yet the data paints a grim picture.
British Columbia, a pioneer in decriminalization and “safe supply” initiatives, has seen overdose deaths steadily climb. Toronto’s Mayor recently echoed support for a similar approach, a request thankfully denied by federal authorities after witnessing the disastrous results in B.C.
The numbers are stark. In 2015, Toronto recorded 137 opioid overdose deaths. By 2024, that number had soared to 467 – more than three times higher. While preliminary figures for the current year suggest a slight decline, it’s a fragile improvement, coinciding with the province’s decision to close several “safe injection sites.”
The current policies, embraced by those in power, are demonstrably failing. Continuing down the same path, expecting different results, is the definition of folly. A fundamental shift in approach is desperately needed, a willingness to acknowledge the consequences of current strategies.
The city is at a crossroads. The prevailing model has proven ineffective, and the time for change is now. The future of Toronto depends on a willingness to confront this crisis with honesty, courage, and a commitment to solutions that prioritize genuine recovery and lasting well-being.
